{"blog": [], "keywords": [{"value": "Hedge Funds", "name": "subject", "rank": "1", "is_major": "N"}, {"value": "Pershing Square Capital Management", "name": "organizations", "rank": "2", "is_major": "N"}, {"value": "Valeant Pharmaceuticals International Inc", "name": "organizations", "rank": "3", "is_major": "N"}, {"value": "Zoetis Inc", "name": "organizations", "rank": "4", "is_major": "N"}, {"value": "Ackman, William A", "name": "persons", "rank": "5", "is_major": "N"}], "web_url": "http://www.nytimes.com/2016/05/10/business/dealbook/william-ackman-sets-out-to-sell-800-million-in-shares-of-zoetis.html", "document_type": "article", "byline": {"person": [{"lastname": "STEVENSON", "firstname": "Alexandra", "role": "reported", "organization": "", "rank": 1}, {"lastname": "PICKER", "firstname": "Leslie", "role": "reported", "organization": "", "rank": 2}], "original": "By ALEXANDRA STEVENSON and LESLIE PICKER"}, "type_of_material": "News", "multimedia": [{"url": "images/2016/05/10/business/10db-ackman/10db-ackman-thumbWide.jpg", "legacy": {"wide": "images/2016/05/10/business/10db-ackman/10db-ackman-thumbWide.jpg", "wideheight": "126", "widewidth": "190"}, "subtype": "wide", "type": "image", "width": 190, "height": 126}, {"url": "images/2016/05/10/business/10db-ackman/10db-ackman-articleLarge.jpg", "legacy": {"xlarge": "images/2016/05/10/business/10db-ackman/10db-ackman-articleLarge.jpg", "xlargeheight": "400", "xlargewidth": "600"}, "subtype": "xlarge", "type": "image", "width": 600, "height": 400}, {"url": "images/2016/05/10/business/10db-ackman/10db-ackman-thumbStandard.jpg", "legacy": {"thumbnail": "images/2016/05/10/business/10db-ackman/10db-ackman-thumbStandard.jpg", "thumbnailheight": "75", "thumbnailwidth": "75"}, "subtype": "thumbnail", "type": "image", "width": 75, "height": 75}], "section_name": "Business Day", "word_count": "339", "source": "The New York Times", "subsection_name": "DealBook", "lead_paragraph": "His Pershing Square Capital has had a difficult year, particularly over its stake in Valeant, the drug company that has come under intense scrutiny.", "pub_date": "2016-05-10T00:00:00Z", "news_desk": "Business", "headline": {"main": "William Ackman Sets Out to Sell $800 Million in Shares of Zoetis"}, "print_page": null, "snippet": "His Pershing Square Capital has had a difficult year, particularly over its stake in Valeant, the drug company that has come under intense scrutiny.", "_id": "573107de38f0d81c1525b4fe", "slideshow_credits": null, "abstract": null}